glp-1 companies stock Pharma's Obesity Strategy: Catching the Next Big Wave Allurion Stock Triples on Plan

99%+ purity, COA verified

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

In summary, it contains: Probiotic Blend: (Clostridium butyricum WB-STR-0006,Akkermansia muciniphila WB-STR-0001,Bifidobacterium infantis), Chicory inulin

But is the idea that they prevent dementia true

Primary outcomes included serious adverse events and retained gastric products based on patient records, procedure reports, and procedural videos